A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

Running, not enrolling

Conditions studied: Breast Cancer, Melanoma

In brief

Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.

Key facts

Study ID

NCT05488483

Run by

Memorial Sloan Kettering Cancer Center

People needed

12

Starts

2022-07-27

Expected to finish

2026-07-27

Last updated by the study team

2026-02-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Participant is a female or male who is 18 years of age or older.
• Participant must meet one of the following:
• Suspicious breast imaging finding detected on either mammography, ultrasound, or MRI that is visible on ultrasound and therefore recommended for ultrasound-guided breast biopsy (BI-RADS 4 suspicious abnormality; BI-RADS 5, highly suggestive for malignancy)
• No previous treatment for breast cancer
• Diagnosis of melanoma

You may not qualify if…

• Life expectancy < 3 months

Where it is running

• Memorial Sloan Kettering Bergen (Consent only ) — Montvale, New Jersey, United States
• Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) — Commack, New York, United States
• Memorial Sloan - Kettering Cancer Center — New York, New York, United States
• Helmholtz Institute (Data Analysis Only) — Munich, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.